derivative may be useful in the management and treatment of cocaine addiction and its neurotoxic effect.
The effect of acute cocaine treatment on extracellular levels of glutamate and taurine are shown in Figure 1 . Although, there were small decreases in interstitial striatal levels of glutamate and taurine in the acute cocaine treated rats compared to control group, these differences did not reach statistical significance. This observation regarding extracellular concentrations of glutamate following acute cocaine administration is in agreement with Miguenes et al. who reported similar results after 1 mg/kg intravenous cocaine treatment in the nucleus accumbens 12 . Other investigators found higher concentrations of extracellular glutamate in the nucleus accumbens after a relatively high dose of 30 mg/kg intrperitoneal cocaine treatment 13 . Previously, a dose of 15 mg/kg of systemic cocaine was shown to release somatodendritic dopamine that stimulated dopamine D1 receptors that in turn increased release of glutamate in the ventral tagmental area 14 . In contrast, it appears that lower doses of cocaine do not increase the levels of dopamine to a sufficient degree to activate release of glutamate in the synaptic cleft in the striatum (Fig. 1) . Our microdialysis experiments show that basal synaptic levels of striatal glutamate in rats receiving chronic cocaine decreased significantly compared to the control group (Fig. 2) . Interestingly, in the chronic cocaine treated group, the synaptic level of taurine increased by about 38% compared to the control group; but this difference did not reach statistical significance (Fig. 2) . The mechanism for the reduction of extracellular glutamate following repeated cocaine administration may be due to a decrease in the activity of cysteine/glutamate exchange that was reported in the nucleus When our chronically cocaine treated group was challenged by an intraperitoneal administration of 10 mg/kg cocaine, a significant increase in extracellular concentrations of both glutamate and taurine were noted (Fig. 3) . There are two possible mechanisms that may be involved in the dramatic increase of the synaptic levels of glutamate after chronic cocaine treatment. First, repeated cocaine exposure may increase the number of dopamine D1 receptors that could enhance glutamate release 14 . Such observation would suggest that chronic cocaine might, at least in part, cause neurotoxicity mediated by the release of glutamate. Second, repeated cocaine administration may desensitize group II metabotropic glutamate receptors in several brain areas 16, 17 and subsequently enhance glutamate release (Fig. 3 ).
There are no previous reports on the release of endogenous taurine in the synaptic cleft after either acute or chronic cocaine treatment. Taurine has been shown to be a neuroprotective agent in numerous investigations 10 and several mechanisms for its neuroprotective effects have been proposed. Most of the studies have suggested antagonism of the glutamate-induced excitotoxicity. For example, it has been proposed that taurine may reduce glutamate-induced cell death by augmentation of mitotochondrial function and the regulation of intracellular (cytoplasmic and intramitochondrial) calcium homeostasis 18 . Taurine was also shown to decrease D-[ 3 H]aspartate (a non-metabolized analog of glutamate) release from mouse corticostriatal slices by the activation of a chloride channel that is insensitive to regulation by GABA and/or strychnine-sensitive glycine receptors 19 . Moreover, acamprosate (calcium acetylhomotaurine), a synthetic analog of taurine has been reported to reduce NMDA receptor activation either through partial agonistic activity at the spermidine site or through its action at the metabotropic glutamate receptors 20 . Thus, multitude of mechanisms may be involved in the diminution of glutamate-induced excitotoxicity by taurine making it a good neuroprotective agent.
Although, taurine and its synthetic analog acamprosate are known to be neuroprotective agents that are used in the treatment of drug addiction 20, 23, 24 , no previous investigation has demonstrated spontaneous release of taurine in the mammalian brain by substances of abuse. We report spontaneous release of taurine after chronic, but not acute cocaine treatment (Figs. 1 and 3 ). The amount of taurine released following acute administration of cocaine was not significantly different from control. This may be related to the dose of the drug or the duration between drug administration and collection of samples for microdialysis. Nevertheless, the results of our study suggest that the mammalian brain has a unique ability to counteract insult to neuronal tissue caused by glutamate in response to substances of abuse. Clearly, released taurine is not sufficient to completely neutralize glutamate-induced excitotoxicity in all cases. Consequently, excessive intake of substances of abuse would lead to the development of drug addiction despite mammalian brains' effort to mitigate these adverse effects by the release of endogenous taurine. Nonetheless, taurine and/or acamprosate have been found to be of therapeutic value in neuronal protection and in the management of cocaine, alcohol, and morphine addiction [20] [21] [22] . Future studies may determine if prior intake of taurine or acamprosate would be of preventive value in mitigating neurotoxicity and addictive sequela to exposure to drugs of abuse.
The extracellular levels of glutamate and taurine were measured by microdialysis followed by high-pressure-liquid-chromatography (HPLC) in striata of male CD rats after acute and chronic administrations of cocaine. Rats were anesthetized with 60 mg/kg intraperitoneal pentobarbital and a microdialysis guide cannula was surgically implanted in the striatum using these coordinates: AP, +0.7 mm; ML, +2 .7 mm; DV -6.0 mm 25 .
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